Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
69.60
+0.40 (0.58%)
Nov 16, 2026, 5:35 PM CET

BME:ROVI Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
828.59743.48763.75829.51817.7648.68
Revenue Growth
14.41%-2.65%-7.93%1.44%26.06%54.46%
Cost of Revenue
279.75271.9296.04346.17305.27268.84
Gross Profit
548.85471.59467.71483.34512.43379.84
Selling, General & Admin
185.1160.47158.26147.02129.99103.36
Other Operating Expenses
160.1107.6102.7392.52105.8474.96
Operating Expenses
381.24298.45289.01263.87258.69199.68
Operating Income
167.61173.14178.71219.47253.74180.15
Interest Expense
-3.86-2.56-1.99-0.95-0.85-0.91
Interest & Investment Income
0.910.510.030.010.010.07
Earnings From Equity Investments
0.20.06-0.14-0.130.20.18
Currency Exchange Gain (Loss)
0.08-0.210.3-0.09-0.82-0.18
Other Non Operating Income (Expenses)
27.4912.330.792.093.933.4
EBT Excluding Unusual Items
192.42183.26177.69220.41256.21182.72
Gain (Loss) on Sale of Investments
----1.76-
Asset Writedown
-----0-0.1
Other Unusual Items
62.35-----
Pretax Income
254.77183.26177.69220.41257.97182.63
Income Tax Expense
49.3442.940.8150.1158.329.55
Earnings From Continuing Operations
205.43140.36136.88170.3199.67153.08
Minority Interest in Earnings
0.140.080.010.040-
Net Income
205.57140.44136.88170.34199.67153.08
Net Income to Common
205.57140.44136.88170.34199.67153.08
Net Income Growth
69.68%2.60%-19.64%-14.69%30.44%150.71%
Shares Outstanding (Basic)
515151535355
Shares Outstanding (Diluted)
515151535355
Shares Change
--0.13%-3.73%-0.51%-3.50%0.03%
EPS (Basic)
4.022.752.673.203.732.76
EPS (Diluted)
4.022.752.673.203.732.76
EPS Growth
-2.73%-16.53%-14.25%35.31%150.36%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
120.78121.8779.1659.45186.88109.22
Free Cash Flow Per Share
2.362.381.551.123.501.97
Dividend Per Share
-0.9590.9351.1041.2940.956
Dividend Growth
-2.60%-15.28%-14.69%35.39%150.68%
Gross Margin
66.24%63.43%61.24%58.27%62.67%58.55%
Operating Margin
20.23%23.29%23.40%26.46%31.03%27.77%
Profit Margin
24.81%18.89%17.92%20.53%24.42%23.60%
Free Cash Flow Margin
14.58%16.39%10.37%7.17%22.86%16.84%
EBITDA
195.67195.54199.62238.02271.33196.56
EBITDA Margin
23.61%26.30%26.14%28.69%33.18%30.30%
D&A For EBITDA
28.0622.3920.9118.5417.5916.41
EBIT
167.61173.14178.71219.47253.74180.15
EBIT Margin
20.23%23.29%23.40%26.46%31.03%27.77%
Effective Tax Rate
19.37%23.41%22.97%22.73%22.60%16.18%
Advertising Expenses
-1821.7421.7519.9912.71